Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer
NCT00046527
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
460
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Neoplasms
Metastases, Neoplasm
Interventions
DRUG:
ABI-007
Sponsor
Celgene Corporation